In this paper the authors reviews the anaemia in cancer patients, its mechanisms, diagnosis, and therapeutics, especially the indications for blood transfusion and the use of recombinant human erythropoietin. Also, the author reviews the impact of anaemia in quality of life and in the outcome of therapy and of cancer itself.